Affymax Inc. (OTCMKTS:AFFY – Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $0.00 and traded as high as $0.0020. Affymax shares last traded at $0.0020, with a volume of 1,500 shares trading hands.
Affymax Stock Performance
Affymax Company Profile
The company’s principal product was peginesatide, marketed in the United States as Omontys. Peginesatide was developed to treat anemia associated with chronic kidney disease and received U.S. regulatory approval in 2012.
See Also
- Five stocks we like better than Affymax
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Affymax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affymax and related companies with MarketBeat.com's FREE daily email newsletter.
